Table A1.
Distribution of histological diagnoses.
| Cohort | Histology | Subtype | n | % |
|---|---|---|---|---|
| Training | benign | serous | 27 | 35.5% |
| dermoid | 19 | 25.0% | ||
| endometrioid | 14 | 18.4% | ||
| functional | 11 | 14.5% | ||
| others | 3 | 3.9% | ||
| n/a | 2 | 2.6% | ||
| total | 76 | 100% | ||
| malignant | HGSOC | 161 | 79.3% | |
| endometrioid | 19 | 9.4% | ||
| borderline | 10 | 4.9% | ||
| CCC | 4 | 2.0% | ||
| undifferentiated | 4 | 2.0% | ||
| LGSOC | 3 | 1.5% | ||
| Met-GI | 1 | 0.5% | ||
| SCST | 1 | 0.5% | ||
| total | 203 | 100% | ||
| Validation | benign | n/a | 21 | 70.0% |
| functional | 5 | 16.7% | ||
| serous | 3 | 10.0% | ||
| others | 1 | 3.3% | ||
| total | 30 | 100% | ||
| malignant | HGSOC | 37 | 78.7% | |
| LGSOC | 4 | 8.5% | ||
| borderline | 2 | 4.3% | ||
| mucinous | 2 | 4.3% | ||
| endometrioid | 1 | 2.1% | ||
| mixed | 1 | 2.1% | ||
| total | 47 | 100% |
HGSOC—high-grade serous ovarian cancer, LGSOC—low-grade serous ovarian cancer, CCC—clear cell carcinoma, SCST—sex-cord stromal tumor, Met-GI—metastatic tumor from gastrointestinal tract, n/a—not available.